MétaCan
Menu
Back to cohort
Record W2114702694 · doi:10.1186/1546-0096-6-s1-s13

7.3 Successful use of anakinra, a soluble IL-1 receptor antagonist, in pediatric rheumatic diseases associated macrophage activation syndrome/reactive hemophagocytic lymphohistiocytosis

2008· article· en· W2114702694 on OpenAlexaff
PM Miettunen, Aarthi Jayanthan, Aru Narendran

Bibliographic record

VenuePediatric Rheumatology · 2008
Typearticle
Languageen
FieldMedicine
TopicAutoimmune and Inflammatory Disorders Research
Canadian institutionsUniversity of Calgary
Fundersnot available
KeywordsAnakinraMacrophage activation syndromeMedicineHemophagocytic lymphohistiocytosisRheumatologyImmunologyMacrophageAntagonistInternal medicineInterleukin 1 receptor antagonistReceptor antagonistReceptorArthritisDisease

Abstract

fetched live from OpenAlex

Increased interleukin 1 (IL-1) production characterizes macrophage activation syndrome/reactive hemophagocytic lymphohistiocytosis (MAS/rHLH), a potentially lethal complication of pediatric rheumatic diseases. Standard treatment (corticosteroids, cyclosporine, +/- IVIg) is not always effective. To test effectiveness of anakinra, a soluble IL-1 receptor antagonist, in pediatric rheumatology patients who failed to respond to standard MAS/rHLH therapy. 6 pediatric rheumatology patients (3 F:3 M); mean (range) age 8.14 (0.5–13.3) years, with MAS/rHLH were enrolled (SoJIA n = 4; Churg Strauss vasculitis n = 1; and infant onset ANCA +ve pulmonary renal syndrome n = 1). The infant patient was moribund in ICU. Histiocytosis society's 2004 criteria (HLH2004), including a T-cell activation marker, soluble IL-2 receptor (sIL2r), were used to confirm MAS/rHLH. Subcutaneous anakinra (2 mg/kg/day) was added to existing therapy (high dose IV Methylprednisolone n = 5/6; IVIg n = 6/6, and cyclosporine n = 5/6). HLH2004 specified clinical and laboratory data were collected pre, 48 hours, and 2 weeks after initiation of anakinra; including sIL2r in 3/6 patients. All patients defrevesced within 24 hours of first anakinra dose, and ventilatory and dialysis support was discontinued within 96 hours in the ICU patient. All patients recovered from MAS/rHLH by 2 weeks; 5/6 pts discontinued corticosteroids by 5 weeks. Abnormally elevated baseline sIL2r resolved by 48 hours post first dose of anakinra in all 3 patients tested. 1) Anakinra, in combination with corticosteroids, IVIG, +/- cyclosporine, was effective in controlling MAS/rHLH in all patients, allowing rapid discontinuation of corticosteroids in 5/6 patients. 2) Elevated baseline sIL2r level normalized rapidly following anakinra, suggesting resolution of abnormal T-cell activation.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.003
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesMeta-epidemiology (narrow)
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.011
Threshold uncertainty score1.000

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0000.003
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0020.000
Bibliometrics0.0010.002
Science and technology studies0.0000.000
Scholarly communication0.0000.001
Open science0.0000.000
Research integrity0.0000.001
Insufficient payload (model declined to judge)0.0000.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.023
GPT teacher head0.264
Teacher spread0.241 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one teacher head, not a consensus.

Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations5
Published2008
Admission routes1
Has abstractyes

Explore more

Same venuePediatric RheumatologySame topicAutoimmune and Inflammatory Disorders ResearchFrench-language works237,207